Axim Biotechnologies Inc (AXIM)

[Tiresias]

One of the other concerns about home testing, as is being highlighted around the world with rapid tests for Covid-19, is the inability of many to use them propertly, requiring a follow up PRC test to qualify the test results from the home kit. Technology will play a future greater role in diagnosis than home test kits will which will remove the possibility of higher than acceptance false test results such as what we now see with constant blood sugar level testing allowing for the automatic injection of insulin in amounts dictated by the monitor with a subcutaneous contact point.